Journal
EPIGENETICS
Volume 16, Issue 8, Pages 819-837Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/15592294.2020.1827722
Keywords
N6-methyladenosine; Immune system; Anti-inflammatory immunity; Anti-viral immunity; Anti-tumour immunity
Funding
- Innovation Fund for Outstanding Doctoral Candidates of Peking University Health Science Center [71013Y2029]
Ask authors/readers for more resources
This review systematically examines the role of m6A modification in regulating immune cells and its implications in anti-inflammatory, anti-viral, and anti-tumour immunity. Understanding the crosstalk between m6A modification and the immune system is crucial for uncovering new pathogenic pathways and developing promising therapeutic targets for diseases.
N6-methyladenosine (m6A), the most prevalent RNA internal modification, is present in most eukaryotic species and prokaryotes. Studies have highlighted an intricate network architecture by which m6A epitranscriptome impacts on immune response and function. However, it was only until recently that the mechanisms underlying the involvement of m6A modification in immune system were uncovered. Here, we systematically review the m6A involvement in the regulation of innate and adaptive immune cells. Further, the interplay between m6A modification and anti-inflammatory, anti-viral and anti-tumour immunity is also comprehensively summarized. Finally, we focus on the future prospects of m6A modification in immune modulation. A better understanding of the crosstalk between m6A modification and immune system is of great significance to reveal new pathogenic pathways and to develop promising therapeutic targets of diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available